The outlook of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the patent expiration in key territories has introduced significant volatility. Investors are now grappling with the effect of generic compe